>
//
>
Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.
"Japanese Firm Moving into U.S. Condom Market"
United Press International (12/21/88)
Stratford, Conn.--Japan's largest condom maker is looking to corner a part of the market in the U.S., where the AIDS epidemic has contributed to a yearly increase in sales of about 25 percent since 1985. Okamoto USA, Inc., which controls 60 percent of the condom market in Japan, plans a $2 million print advertisement in the coming year to market four brands, including one targeted to women. The company's general manager, Hisayuki Naito, says condoms are "a very positive and very serious product" in Japan, unlike the U.S., where "people joke about them." One ad the company will use features two fingers stretching a condom. Okamoto says it will be the first American ad to actually show a condom. Commenting on the company's ability to break into the U.S. market, Salomon Brothers Inc. analyst Diana Temple says, 'If people are embarrassed to even say the word 'condom,' they're going to be reluctant to search for anything other than the tried and true brands."
881221
AD880398
Copyright © 1988 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
< type="text/java "> > < type="text/java " src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> >
AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. and many more are available free online at --> .